nach oben

Erschienen in:

01.03.2023 | News item

Two lots of aztreonam recalled in Canada due to cracked vials

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Health Canada is advising that Gilead Sciences has recalled two lots (032168 and 033357) of the cystic fibrosis drug aztreonam [Cayston] (DIN 02329840) due to the potential of cracked glass vials, which may introduce glass particles into the medication. A cracked glass vial could cause potential injury or lead to potential contamination or a reduced dose. …

Two lots of cystic fibrosis drug Cayston recalled due to the potential of cracked glass vials Internet Document : 20 Mar 2023. Available from: URL: https://recalls-rappels.canada.ca/en/alert-recall/two-lots-cystic-fibrosis-drug-cayston-recalled-due-potential-cracked-glass-vials

Titel: Two lots of aztreonam recalled in Canada due to cracked vials
Publikationsdatum: 01.03.2023
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-35988-y

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Two lots of aztreonam recalled in Canada due to cracked vials

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Cisplatin/gemcitabine

Lidocaine/sotalol

Multiple drugs

Calcitriol/unspecified phosphates

Atropine/distigmine-bromide/norepinephrine

Adenosine/diltiazem